Last reviewed · How we verify

NCT07242560

Epidural Catheter and Port-Related Infections in Pain Clinic Patients

Active, enrolled Last updated 21 November 2025
What this trial tests

trial in Epidural Catheter-Related Infection in 351 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
1 January 2002
Primary endpoint
1 January 2025
1 December 2025

Quick facts

Lead sponsorMesut Bakır
StatusActive, enrolled
Study typeOBSERVATIONAL
Enrollment351
Start date1 January 2002
Primary completion1 January 2025
Estimated completion1 December 2025
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Mesut Bakır — full company profile →

Who can join

18 and older, any sex, with Epidural Catheter-Related Infection or Hospital-Acquired Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This retrospective observational study aims to evaluate the incidence and risk factors of infection associated with epidural catheter and port applications performed in the Pain Clinic of Mersin University Faculty of Medicine. Data from patients who underwent epidural catheter or port placement between January 2002 and January 2025 will be analyzed. Demographic data, catheter duration, insertion level, type of device, clinical indication, and microbiological culture results will be examined to determine factors influencing infection development. The study seeks to identify common pathogens and assess potential relationships between procedural characteristics and infection risk. The ultimate goal of this research is to contribute to improving infection prevention strategies and ensuring patient safety in interventional pain management practices.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Epidural Catheter- and Port-Related Infections in Pain Medicine: A Cohort Study from a Chronic Pain Center with Long-Term Catheterization.
    Bakır M, Bayburtluoğlu E, İlcan B, Yavuz K, et al · · 2026 · PMID 42075676 · DOI 10.3390/pathogens15040349

Verify or expand the search:

Other Mesut Bakır trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07242560.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing